Aphria Inc. Acquires CannWay Pharmaceuticals Inc.

LEAMINGTON, ONTARIO--(Marketwired - Jan. 14, 2016) -

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH) has acquired a 100 per cent interest in CannWay Pharmaceuticals Inc. ("Cannway") - a medical support service created by veterans - as part of the Company's on-going commitment to enhance and improve patient care (the "Transaction"). Pursuant to the Transaction, CannWay's founders have become shareholders in Aphria on the terms described below.

Under the terms of the Transaction, Aphria has issued 3.6 million shares from treasury to the previous owners of CannWay, 1.8 million of which will be held in escrow until certain operational metrics are achieved. In the event the operational metrics are not achieved, the shares will be released from escrow to Aphria and cancelled. The Transaction provides an established patient-base for Aphria with potential for increased growth through...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.